The National Institutes of Health (NIH) has posted a grant opportunity titled "CCRP Initiative: Chemical Threat Agent-induced Pulmonary and Ocular Pathophysiological Mechanisms (R01 Clinical Trial Not Allowed)". This grant aims to support research that seeks to understand the mechanisms of chemical toxicity and identify potential molecular/genetic targets that reduce the acute effects of chemical threat agents on the eyes and lungs. The discoveries made through this research can lead to the exploration of therapeutic countermeasures through early stage development efforts supported by the Countermeasures Against Chemical Threats (CounterACT) NIH-wide program, which is a component within the Chemical Countermeasures Research Program (CCRP). The grant does not require cost sharing or matching and falls under the category of funding activity related to health. The eligible applicants include various institutions and organizations such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), eligible agencies of the Federal Government, faith-based or community-based organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), regional organizations, Tribally Controlled Colleges and Universities (TCCUs), U.S. Territories or Possessions. Non-domestic (non-U.S.) entities and components are not eligible to apply. The grant opportunity will close on September 23, 2026, and more information can be found at the following link: http://grants.nih.gov/grants/guide/rfa-files/RFA-ES-24-005.html. For any inquiries, contact NIH Grants Information at grantsinfo@nih.gov.